Amulet Pharmaceuticals
Rockville · Founded 2006
About Amulet Pharmaceuticals
Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECH™ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.
Company Facts
- Founded: 2006
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2007)
- Website: http://www.amuletpharma.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/amulet-pharmaceuticals-1846875 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.